Filing Details

Accession Number:
0001225208-13-013160
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-23 17:20:49
Reporting Period:
2013-05-23
Filing Date:
2013-05-23
Accepted Time:
2013-05-23 17:20:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
14272 Bristol Myers Squibb Co BMY Pharmaceutical Preparations (2834) 220790350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1457948 J Beatrice Cazala Bristol-Myers Squibb Company
345 Park Avenue
New York NY 10154
Evp Commercial Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.10 Par Value Acquisiton 2013-05-23 73,501 $21.88 339,746 No 4 M Direct
Common Stock, $0.10 Par Value Acquisiton 2013-05-23 42,911 $27.36 382,657 No 4 M Direct
Common Stock, $0.10 Par Value Disposition 2013-05-23 96,000 $46.99 286,657 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.10 Par Value Option (right to buy) Disposition 2013-05-23 73,501 $0.00 73,501 $21.88
Common Stock, $0.10 Par Value Option (right to buy) Disposition 2013-05-23 42,911 $0.00 42,911 $27.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-09-06 No 4 M Direct
0 2016-09-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.10 Par Value 3,743 Indirect By BMY Savings & Investment Program
Footnotes
  1. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $46.96 to $47.03, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  2. Based on a plan statement as of the end of the most recent fiscal quarter.
  3. Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 7, 2008.
  4. Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 12, 2007.